ARCT - Arcturus Therapeutics EPS beats by $0.02 misses on revenue August, 10 2020 04:10 PM Arcturus Therapeutics Ltd. Arcturus Therapeutics (NASDAQ:ARCT): Q2 GAAP EPS of -$0.55 beats by $0.02.More news on: Arcturus Therapeutics Holdings Inc., Earnings news and commentary, Healthcare stocks news, Read more ...